Allarity Therapeutics, Inc. 10-Q filing
Filed 2025-08-15 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001437749-25-027146
- Form type
- 10-Q
- CIK
- 0001860657
- Primary document
- https://www.sec.gov/Archives/edgar/data/1860657/000143774925027146/allr20250630_10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Allarity Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-7.2M | - | - |
| Net Income | $-5.1M | - | - |
| Eps Basic | -0.38 | - | - |
| Cash And Equivalents | $17.8M | - | - |
| Total Assets | $21.2M | - | - |
| Total Liabilities | $9.0M | - | - |
| Shareholders Equity | $12.2M | - | - |
| Operating Cash Flow | $-8.2M | - | - |